These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1008301)

  • 1. [Arteriosclerosis and atherogenic drugs].
    Navarrete Pando G
    Angiologia; 1976; 28(1):12-20. PubMed ID: 1008301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic factors in atherosclerosis].
    Coccheri S
    Bull Sci Med (Bologna); 1967; 139(4):474-80. PubMed ID: 4236949
    [No Abstract]   [Full Text] [Related]  

  • 3. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions.
    Haapanen A; Leinonen A; Seppänen S
    Ann Radiol (Paris); 1984; 27(4):340. PubMed ID: 6204575
    [No Abstract]   [Full Text] [Related]  

  • 4. [Angiocyclan in the treatment of vascular diseases. Controlled clinical results].
    Bracale GC; Renda A
    Minerva Cardioangiol; 1975 Mar; 23(3):170-6. PubMed ID: 1128768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
    Ferliga G
    G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Laboratory investigations on the effect of a heparinoid].
    Harmanci N; Akman N; Ulutin ON
    Rev Med Moyen Orient; 1965; 22(6):541-5. PubMed ID: 5217700
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic therapy].
    Vreeken J
    Ned Tijdschr Geneeskd; 1985 Sep; 129(36):1720-1. PubMed ID: 3932888
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the activity of a sulfomucopolysaccharide extractive on the blood-lipid and fibrinolytic pattern in atherosclerotic disease].
    Isidori A; Recchia O; Butti A
    Minerva Med; 1967 Mar; 58(19):779-82. PubMed ID: 4164416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of atherosclerosis].
    Villaverde MM; Sadow HS
    Rev Clin Esp; 1967 Jan; 104(1):67-73. PubMed ID: 5596051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complex therapy of arteriosclerosis of the lower limbs].
    Bocharov AA; Kohhan EP
    Khirurgiia (Mosk); 1971 Dec; 47(12):37-9. PubMed ID: 5141186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis].
    Etchevés JC; Buzzi RM; Bruno E; Sacanell C
    Hospital (Rio J); 1968 Sep; 74(3):807-14. PubMed ID: 5310120
    [No Abstract]   [Full Text] [Related]  

  • 13. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of coronary arteriosclerosis and its complications].
    Giordano MP; Allegri M
    Clin Ter; 1972 Feb; 60(3):259-74. PubMed ID: 4665993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modifications of the renogram and scansiometry with hippuran-I 131 and chlormerodrin-Hg 203 , studied with Pho Gamma 3, in arteriosclerosis treated with polysulfoester of pentosan (SP-54)].
    Indovina I; Salerno L; Licata G
    Boll Soc Ital Cardiol; 1971; 16(4):173-83. PubMed ID: 4110135
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapeutic problem of arteriosclerotic arteriopathies of the lower extremities].
    Gatta L; Montemurro G
    Minerva Med; 1980 Apr; 71(16):1173-9. PubMed ID: 7375035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic fibrinolysis and arterial occlusive disease].
    Lasch HG; Schöndorf TH
    Verh Dtsch Ges Inn Med; 1981; 87():314-23. PubMed ID: 7331461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A; Citarrella P; Carreca I
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A; Citarrella P; Malleo C
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract]   [Full Text] [Related]  

  • 20. The fibrinolytic system in arteriosclerosis.
    O'Brien ET
    J Ir Med Assoc; 1969 Jun; 62(384):203-12. PubMed ID: 4892241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.